GlassScriptPhysician profile
Cindy A Nakhla
NPI 1265750202
$979.93
in general payments reported to CMS, 2019-2025
16 companies · $80.24 in 2025
The $80.24 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $24.73 · 2021: $122 · 2022: $172 · 2023: $279 · 2025: $80.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $264.77 | 2019-2025 | Aptima |
| Organon LLC | $141.33 | 2021-2023 | Nexplanon |
| Abbvie INC. | $120.66 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $89.75 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $76.52 | 2019-2023 | Vaxneuvance, Pneumovax 23, Gardasil 9 |
| Roche Diagnostics Corporation | $72.48 | 2019-2021 | |
| Astellas Pharma US INC | $32.86 | 2025 | Veozah |
| Pfizer INC. | $28.06 | 2023 | |
| Allergan, INC. | $24.81 | 2019 | |
| Abbott Laboratories | $22.97 | 2025 | Alinity M |
| Gilead Sciences, INC. | $21.00 | 2022 | |
| Glaxosmithkline, LLC. | $20.27 | 2022 | |
| Sanofi Pasteur INC. | $18.43 | 2023 | |
| Dexcom, INC. | $16.77 | 2022 | |
| Cranial Technologies, INC | $15.21 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $14.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Nakhla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.